{"entity":{"type":"insider","cik":"0001266427","url":"/insider/0001266427","json_url":"/insider/0001266427.json","name":"LIEBERBURG IVAN M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":15,"first":"2015-01-07","last":"2021-03-09","span_basis":"filed_date"},"name_variants":[{"name":"LIEBERBURG IVAN M","source":"filing","n_filings":15,"first_seen":"2015-01-07","last_seen":"2021-03-09"}],"transactions":[{"id":4350749,"accession":"0000899243-21-010812","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400005.0,"shares_display":"400,005","price_per_share":181.14999812502344,"price_display":"181.15","price_state":"stated","total_value":72460905.0,"total_display":"72,460,905.00","total_whole":"72,460,905","shares_owned_after":2000000.0,"shares_owned_after_display":"2,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider","n_lines":4},{"id":2908017,"accession":"0000899243-20-030060","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-030060","line_url":"/filing/0000899243-20-030060","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LEWIS JOSEPH; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Davis Aaron I.; Boxer Capital, LLC; MVA Investors, LLC; Fuglesang Christopher","owner_display_name":"LEWIS JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":202.0,"price_display":"202.00","price_state":"stated","total_value":80800000.0,"total_display":"80,800,000.00","total_whole":"80,800,000","shares_owned_after":1404610.0,"shares_owned_after_display":"1,404,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-10-30","scope":"insider","n_lines":2},{"id":4645621,"accession":"0000899243-17-000987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-000987","line_url":"/filing/0000899243-17-000987","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LAPPE RODNEY W; LEWIS JOSEPH; Boxer Capital, LLC; Davis Aaron I.; Reisman Neil; MVA Investors, LLC; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Fuglesang Christopher","owner_display_name":"LAPPE RODNEY W","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":286163.0,"shares_display":"286,163","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":1602512.8,"total_display":"1,602,512.80","total_whole":"1,602,513","shares_owned_after":1037994.0,"shares_owned_after_display":"1,037,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-06","filed_date":"2017-01-10","scope":"insider","n_lines":2},{"id":8887540,"accession":"0001209191-15-084317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-084317","line_url":"/filing/0001209191-15-084317#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":16.23,"price_display":"16.23","price_state":"stated","total_value":48690.0,"total_display":"48,690.00","total_whole":"48,690","shares_owned_after":48000.0,"shares_owned_after_display":"48,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-07","filed_date":"2015-12-09","scope":"insider"},{"id":8786425,"accession":"0001209191-15-078490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-078490","line_url":"/filing/0001209191-15-078490#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":51000.0,"shares_owned_after_display":"51,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-04","scope":"insider"},{"id":8886815,"accession":"0001209191-15-074683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-074683","line_url":"/filing/0001209191-15-074683#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":50250.0,"total_display":"50,250.00","total_whole":"50,250","shares_owned_after":54000.0,"shares_owned_after_display":"54,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-05","filed_date":"2015-10-07","scope":"insider"},{"id":8793890,"accession":"0001209191-15-070176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-070176","line_url":"/filing/0001209191-15-070176#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.13,"price_display":"19.13","price_state":"stated","total_value":57390.0,"total_display":"57,390.00","total_whole":"57,390","shares_owned_after":57000.0,"shares_owned_after_display":"57,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-10","scope":"insider"},{"id":8345420,"accession":"0001209191-15-064185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-064185","line_url":"/filing/0001209191-15-064185#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":24.51,"price_display":"24.51","price_state":"stated","total_value":73530.0,"total_display":"73,530.00","total_whole":"73,530","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"},{"id":8253835,"accession":"0001209191-15-060121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-060121","line_url":"/filing/0001209191-15-060121#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":25.91,"price_display":"25.91","price_state":"stated","total_value":77730.0,"total_display":"77,730.00","total_whole":"77,730","shares_owned_after":63000.0,"shares_owned_after_display":"63,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-06","filed_date":"2015-07-08","scope":"insider"},{"id":8812275,"accession":"0001209191-15-049720","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-049720","line_url":"/filing/0001209191-15-049720#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":17.93,"price_display":"17.93","price_state":"stated","total_value":53790.0,"total_display":"53,790.00","total_whole":"53,790","shares_owned_after":66000.0,"shares_owned_after_display":"66,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8460163,"accession":"0001209191-15-039486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-039486","line_url":"/filing/0001209191-15-039486#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":16.82,"price_display":"16.82","price_state":"stated","total_value":50460.0,"total_display":"50,460.00","total_whole":"50,460","shares_owned_after":69000.0,"shares_owned_after_display":"69,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-04","filed_date":"2015-05-06","scope":"insider"},{"id":8216236,"accession":"0001209191-15-032902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-032902","line_url":"/filing/0001209191-15-032902#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":17.44,"price_display":"17.44","price_state":"stated","total_value":52320.0,"total_display":"52,320.00","total_whole":"52,320","shares_owned_after":72000.0,"shares_owned_after_display":"72,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-06","filed_date":"2015-04-07","scope":"insider"},{"id":8802227,"accession":"0001209191-15-022427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-022427","line_url":"/filing/0001209191-15-022427#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":16.97,"price_display":"16.97","price_state":"stated","total_value":50910.0,"total_display":"50,910.00","total_whole":"50,910","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-04","scope":"insider"},{"id":8936956,"accession":"0001209191-15-009068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-009068","line_url":"/filing/0001209191-15-009068#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":16.77,"price_display":"16.77","price_state":"stated","total_value":50310.0,"total_display":"50,310.00","total_whole":"50,310","shares_owned_after":78000.0,"shares_owned_after_display":"78,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-03","scope":"insider"},{"id":8369003,"accession":"0001209191-15-002843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-002843","line_url":"/filing/0001209191-15-002843#line-1","is_derivative":false,"issuer_cik":"0001266427","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001266427","owner_cik":"0001266427","owner_name":"LIEBERBURG IVAN M","owner_display_name":"LIEBERBURG IVAN M","owner_url":"/insider/0001266427","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":17.59,"price_display":"17.59","price_state":"stated","total_value":52770.0,"total_display":"52,770.00","total_whole":"52,770","shares_owned_after":81000.0,"shares_owned_after_display":"81,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner","n_filings":3,"first_seen":"2017-01-10","last_seen":"2021-03-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001328143","name":"Adamas Pharmaceuticals Inc","url":"/issuer/0001328143","role":"Director","n_filings":12,"first_seen":"2015-01-07","last_seen":"2015-12-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001266427","retrieved_at":"2026-08-23T19:23:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}